Identification of the miR-494-3p/JunD axis provides a potential new molecular target to prevent or treat left ventricular dysfunction in obese patients.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for obesity-related cardiomyopathy; requires human validation before any clinical consideration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Costantino et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: